This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Zacks.com featured highlights Ralph Lauren, Plains All American Pipeline, Brinker, EverQuote and American Airlines
by Zacks Equity Research
Ralph Lauren, Plains All American Pipeline, Brinker, EverQuote and American Airlines have been highlighted in this Screen of The Week article.
5 Stocks With Upgraded Broker Ratings to Invest in Now
by Swayta Shah
Brokers have deeper insights into stocks and the macroeconomic backdrop. One must follow broker rating upgrades to pick stocks like RL, PAA, EAT, EVER & AAL.
EVER Stock Trading at a Premium to Industry: Will You Still Buy It?
by Tanuka De
EverQuote benefits from its exclusive data asset and technology, intensified focus on core P&C markets, streamlined operations and strong financial profile, which poise it for long-term growth.
Here's Why EverQuote (EVER) is a Strong Growth Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Reasons Why Investors Should Retain Principal Financial Stock Now
by Zacks Equity Research
PFG gains from strategic acquisitions, favorable growth estimates, financial stability and effective capital deployment.
Small-Cap Stocks Can Outperform Large-Cap Peers in 2025: 5 Top Picks
by Nalak Das
We have picked five small-cap stocks that have strong growth potential for 2025. These are: TZOO, EVER, LIND, RIGL, GHM.
New Strong Buy Stocks for January 7th
by Zacks Equity Research
AORT, VERX, NN, IMCR and EVER have been added to the Zacks Rank #1 (Strong Buy) List on January 7, 2024.
EG Stock Trading at Discount to Industry at 1.01X: Time to Hold?
by Zacks Equity Research
Everest Group remains poised to gain from strong renewal retention, continued favorable rate increases and prudent capital deployment.
Why EverQuote (EVER) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
RDN Stock Trading at Discount to Industry at 1.02X: Time to Buy?
by Zacks Equity Research
Radian Group stock rallies on the back of an improving mortgage insurance portfolio, declining claims, a solid capital position and effective capital deployment.
Bet on Winning DuPont Analysis & Pick 3 Top Stocks
by Sanghamitra Saha
Do you have more faith in DuPont analysis than simple ROE calculation? Tap EverQuote (EVER), EMCOR Group (EME) and Sprouts Farmers Market (SFM).
Wall Street Analysts See a 78.13% Upside in EverQuote (EVER): Can the Stock Really Move This High?
by Zacks Equity Research
The mean of analysts' price targets for EverQuote (EVER) points to a 78.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
ROOT Stock Skyrockets 627% YTD: Time to Buy Despite Premium Valuation?
by Tanuka De
Despite its expensive valuation, given its focus on driving growth, its price appreciation and its VGM Score of B, you can bet on ROOT stock.
ORI Stock Trading at Discount to Industry at 1.43X: Time to Hold?
by Zacks Equity Research
Old Republic rides on high renewal retention ratios, well-performing Title business, financial flexibility, favorable growth estimates and higher return on capital.
EVER Rallies 51.2% YTD: Time to Add the Stock for Better Returns?
by Zacks Equity Research
EverQuote stock gains from higher quote request volume, solid performance of automotive and other insurance marketplace verticals and favorable growth estimates.
BRO Rallies 53.6% YTD: Time to Buy the Stock for Solid Returns?
by Zacks Equity Research
Brown & Brown remains well-poised for growth on higher core commissions and fees, new business, solid retention, strategic acquisitions and effective capital deployment.
AJG Rallies 35% YTD but Lags Industry: How to Play the Stock
by Zacks Equity Research
Arthur J. Gallagher gains on the back of solid performance of its Brokerage and Risk Management segments, strategic buyouts and effective capital deployment.
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Is EverQuote (EVER) Up 3.3% Since Last Earnings Report?
by Zacks Equity Research
EverQuote (EVER) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
UNM Stock Gains 68.9% YTD: What Should Be Investors' Approach Now?
by Zacks Equity Research
Unum Group stock rallies on favorable benefits experience, higher sales, strong persistency, improved premium income and prudent capital deployment.
Assurant Stock Gains 34% YTD: What Should Be Investors' Approach Now?
by Zacks Equity Research
AIZ stock gains on the back of a well-performing Global Lifestyle business, growth of fee-based capital-light businesses and effective capital deployment.
Bet on Winning DuPont Analysis & Pick 4 Top Stocks
by Sanghamitra Saha
Do you have more faith in DuPont analysis than simple ROE calculation? Tap EverQuote (EVER), Expeditors International of Washington (EXPD), EMCOR Group (EME), and Sprouts Farmers Market (SFM).
Wall Street Analysts Think EverQuote (EVER) Could Surge 67.9%: Read This Before Placing a Bet
by Zacks Equity Research
The mean of analysts' price targets for EverQuote (EVER) points to a 67.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
MGIC Investment Stock Rises 35.3% YTD: More Room for Growth?
by Zacks Equity Research
MTG stock rallies on the back of solid insurance in force, lower delinquency, better housing market fundamentals and solid growth projections.
Earnings Estimates Moving Higher for EverQuote (EVER): Time to Buy?
by Zacks Equity Research
EverQuote (EVER) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.